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Lymphatic dissemination is a key event in cervical cancer progression and related tumor lymphatic markers are
viewed as promising prognostic factor of nodal extension. However, validating such parameters requires an
objective characterization of the lymphatic vasculature. Here, we performed a global analysis of the lymphatic
network using a new computerized method applied on whole uterine cervical digital images. Sixty-eight cases
of cervical neoplasia (12 CIN3, 10 FIGO stage 1A and 46 stage IB1) and 10 cases of normal cervical tissue were
reacted with antibodies raised against D2-40, D2-40/p16 and D2-40/Ki67. Immunostained structures were
automatically detected on whole slides. The lymphatic vessel density (D2-40), proliferating lymphatic vessel
density (D2-40/ki67) and spatial lymphatic distribution in respect to the adjacent epithelium were assessed from
normal cervix to early cervical cancer and correlated with lymphovascular space invasion and lymph node
status. Prominent lymphatic vessel density and proliferating lymphatic vessel density are detected under the
transformation zone of benign cervix and no further increase is noted during cancer progression. Notably, a
shift of lymphatic vessel distribution toward the neoplastic edges is detected. In IB1 cervical cancer, although
intra- and peritumoral lymphatic vessel density are neither correlated with lymphovascular space invasion nor
with lymph node metastasis, a specific spatial distribution with more lymphatic vessels in the vicinity of tumor
edges is predictive of lymphatic dissemination. Herein, we provide a new computerized method suitable for an
innovative detailed analysis of the lymphatic network. We show that the transformation zone of the benign
cervix acts as a baseline lymphangiogenic niche before the initiation of neoplastic process. During cancer
progression, this specific microenvironment is maintained with lymphatic vessels even in closer vicinity to
tumor cells.
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In uterine cervical neoplasms, and in most human
solid tumors, lymphatic vasculature is the common
pathway for initial tumor spread to regional lymph
nodes.1 In addition to tumor size, lymph node
status (positive/negative lymph node metastasis) is
regarded as the strongest prognostic factor for
patient’s cancer-specific survival.2,3 It is widely
used for guiding therapeutic decisions and curren-
tly justifies a systematic lymphadenectomy in early
cervical cancer. Owing to the low rate of positive
lymph node detected (ranging from 12 to 22%)4 and
the potential morbidity associated with a lymph
node dissection, research has focused over recent
years on the identification of primary tumor vari-
ables predictive of lymphatic spread.5,6
In this context, lymphovascular space invasion
has been described as an independent factor predict-
ing tumor aggressiveness.7 More recently, the
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lymphatic vessel density, which witnesses the level
of lymphangiogenesis (formation of new lymphatic
vessels), has been proposed as a new promising
predictive variable of nodal extension.8 Notably,
studies on cervical tissues showed that high levels
of lymphatic vessel density as well as marked
expression of vascular endothelial growth factors
(VEGF)-C and VEGF-D, the two main lymphangio-
genic promoters, are already detected in preinva-
sive neoplasia (CIN3).9–12 A gradual increase of
lymphatic vessel density has been reported in the
peritumoral stroma during cancer progression13–15
and in invasive cervical cancer, Gombos et al15 were
the first to link high peritumoral lymphatic vessel
density with growth factor expression, lymphovas-
cular space invasion, lymph node metastases and
overall survival. Subsequent immunohistochemical
studies on cervical neoplasms confirmed a positive
association between lymphatic vessel density and
lymph node metastases.14,16–21 Taken together, these
results suggest an early lymphangiogenesis switch
with an increased risk of lymphatic dissemination
during cancer progression that could be assessed by
lymphatic vessel density quantification. However,
until recently, lymphatic vessel density quantifica-
tion has relied on the hot spot technique previously
criticized for its subjectivity. The main disadvan-
tages of this approach are its focus on a limited
tumor area and its lack of reproducibility.22
Consequently, no consensus exists on the potential
prognostic value of the tumor lymphatic vasculature
profile in cervical cancer.10,23,24
In order to overcome the major restrictions related
to the conventional hot spot approach, we have
developed an original semi-automated quantifica-
tion method based on computerized image analysis
of lymphatic vessels on whole slide scanned tissue
sections.25 The present work aims at drawing
pathologist’s attention on the interest of a global
lymphatic vasculature analysis on cancer tissues. In
particular, we provide evidence for a so far unappre-
ciated lymphatic niche under the transformation
zone considered as the site where neoplastic
changes occur primarily during the cervical onco-
genic process.26,27 Furthermore, our study demon-
strates that a global stromal evaluation sheds light
on topographical features of the lymphatic vascular
network that are worth considering in cervical
cancer as well as other cancers.
Materials and methods
Tissue Samples
Surgical specimens of 68 patients suffering cervical
neoplasia were obtained from the biobanks of the
University of Lie`ge (CHU, Lie`ge Belgium) and the
Centre Hospitalier Universitaire of Montreal
(CHUM, Hoˆpital Notre-Dame, Montreal Canada)
after study approval by local ethic committees.
Twelve cases of in situ carcinomas (CIN3: presence
of neoplastic cells that occupy the full thickness of
the epithelium), 10 microinvasive lesions (FIGO
stage IA1: neoplastic processr3mm of depth
andr7mm of width) and 46 early uterine cervical
cancers (IB1: clinically visible lesionr4 cm in
greatest axis) were successively collected. Stage
was allocated according to the International Federa-
tion of Gynecology and Obstetrics staging system
(FIGO). Lymph node metastases were detected in
12/46 invasive cases and lymphovascular space
invasion was present in 25/46 surgical specimens.
Ten benign uterine cervical samples were also
obtained from patients treated for non-oncological
reasons (fibroma, menorrhagia, uterine prolapse,
Lynch syndrome). The cervix was sectioned and
sections were oriented according to standard histo-
logical guidelines.28 All tissues were reviewed by a
pathologist blinded to the study purpose. CIN3 and
microinvasive lesions were diagnosed on a cone
biopsy specimen that encompasses a large part of
the tree anatomical regions of the uterine cervix.
Early cervical cancer lesions and benign cervix
samples of 0.5 cm thickness were collected after
radical surgical hysterectomy. For early cervical
cancers, this sampling was performed in the most
infiltrative area. Among representative slides, those
permitting optimal transformation zone (normal
cervix), dyspalsia or micro-invasive cancers evalua-
tion as well as peritumoral stromal immunostaining
were selected.
Immunohistochemisty
Lymphatic vessels, proliferating lymphatic vessels
and tumor cells were identified using a monoclonal
anti-human antibody against podoplanin (D2-40,
1:100; Dako, Heverlee, Belgium), a prediluted multi-
plex cocktail composed of monoclonal mouse anti
D2-40 and rabbit monoclonal anti-Ki67 (ready to
use; Biocare Medial, Concord, USA) and a poly-
clonal rabbit anti CDKN2A/p16INK4a (1:100; Abcam,
Cambridge, UK), respectively.
Virtual Image Acquisition and Processing
Virtual images were acquired with the fully auto-
mated digital microscopy system dotSlide (Olym-
pus, BX51TF, Aartselaar, Belgium). Whole tissue
sections were digitized at high magnification produ-
cing virtual images in which pixels measure
0.4225 mm2. DotSlide providing images in a proprie-
tary format, images were converted into a standard
TIFF format, easier to handle. Thereafter, tumor
cells and lymphatic vessels were computerized as
illustrated in Figure 1. When Ki67-positive lympha-
tic vessel sections were considered, because of low
contrast between podoplanin and Ki67-positive
nuclei, vessels were manually drawn with the help
of the Aperio ImageScope v10.2.1.2314 software.
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The three anatomical regions (exocervix, transfor-
mation zone and endocervix) were delineated on
virtual images by using the Aperio ImageScope
v10.2.1.2314 software. The transformation zone
was defined as the cervical area in which squamous
and columnar epithelia were present in continuity
and/or squamous epithelium was detected with
underlying glands.29 Epithelia of benign cervical
tissues, CIN3 and microinvasive lesions as well as
the boundary between intra- and peritumoral areas
in FIGO 1B1 cervical cancers were delimited in the
same way. Finally, tissues were extracted by a
moment-preserving thresholding method30 applied
on the blue component of the original virtual image.
Figure 1 Illustration of tumor cell and lymphatic vessel detection. Virtual images of immunostained cervical cancer tissues are presented
on the left and corresponding binary images are shown on the right. (a) Tumor cells (brown, left image) and lymphatic vessels (red, left
image) are automatically segmented together thanks to a Maximum Entropy Thresholding performed on the excess red component.
(b) They are automatically distinguished based on the average value of the color presented by each detected structure (44.5 radians¼
tumor cell in white,o3 radians¼ lymphatic vessel in red). (c, d) In order to take into consideration lymphatic vessels in their integrality,
vessel lumens are filled. Background is firstly segmented (c, yellow) and detected structures in close contact with lymphatic wall are
considered (d). (e) Finally, to avoid misinterpretations, non-vascular structures that could have been detected and/or detection mistakes
are manually corrected (green arrows, right image). (f) The final binary image of detected tumor cells and lymphatic vessels (right image)
is obtained after the image processing. Scale bars represent 200mm.
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Owing to high image size that hampers calculation,
all binary images of the detected structures were
decimated according to the procedure described
elsewhere.31 Figure 2 illustrates the different steps
of image processing.
Image Analysis
Image analysis and measurements were performed
using image analysis library Pandore (GREYC, Caen,
France), Aphelion 3.2 (ADCIS, Saint-Contest, France)
and image toolbox of MATLAB 9.2 (MathWorks,
Natick, MA, USA) software. Lymphatic vessel density,
proliferating lymphatic vessel density and spatial
distribution of lymphatic vessel were quantified from
the basal layer of the surface epithelium or neoplastic
edges to tissue border. Lymphatic vessel density and
proliferating lymphatic vessel density were defined as
the number of lymphatic vessels and Ki67-positive
lymphatic vessels per mm2 of tissue, respectively.
Spatial lymphatic vessel distribution analysis was
performed by measuring the Euclidean distance
between the center of mass of each vessel section
and the basal layer of the surface epithelium or
neoplastic edges as previously described.25 For
comparison, curves were normalized taking the
maximum of the control curve at one.
In CIN3, microinvasive and IB1 affected tissues,
the perineoplastic area was defined as the stromal
region located from neoplastic edges to 2mm of
depth. The transformation zone of benign cervix was
Figure 1 (Continued).
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considered as reference to which quantifications
obtained under the neoplastic lesions were com-
pared.
Statistical Analysis and Graphs
For lymphatic vessel density, proliferating lympha-
tic vessel density and vessel distance to epithelium/
tumor border, data were analyzed with GraphPad
Prism 5.0 software (San Diego, CA, USA). Mean
values were each compared using the Mann–
Whitney test to determine whether a difference
between experimental groups could be considered
as significant. Statistical analysis of lymphatic
vessel spatial distribution was performed using a
Wilcoxon non-parametric test with the statistic
toolbox of MATLAB 9.2 software. The level of
statistical significance was set at Po0.05 for all
comparisons. Graphs are presented as scatter plots
of individual data points. Means are presented by
horizontal bars.
Results
Hot Spot versus Computer-Assisted Analysis
Intra- and peritumoral lymphatic vessel density
were first assessed using the hot spot technique by
two independent operators according to the method
described by Weidner et al32 and then compared
with that determined by a computerized method on
46 cases of early cervical cancers. Inter-observer
variability obtained after quantifications within
the hot spot regions reaches 33.8% and 23.6% for
Figure 2 Image processing illustration. (a) Virtual image of whole benign cervical tissue. Lymphatic vessel sections were detected by
immunostaining with the anti-podoplanin antibody (D2-40) and visualized in pink as illustrated at higher magnification in the insert
(top). Lymphatic vessel section edges and lumens were automatically segmented on virtual image (red) while blood vessels were not
detected (star). (b–d) Binary images of detected lymphatic vessel sections (red), tissue (grey) and epithelium (white) were generated.
Exocervix (1), transformation zone (2) and endocervix (3) were manually delineated (white dotted lines). Neoplastic lesions and their
underlying stromal tissues were manually highlighted in CIN3 (c) and microinvasive lesions (d) (green lines). Green arrow represents
tissue under neoplastic lesion that was analyzed. (e) Virtual image of whole cervical cancer slide. In invasive lesions, lymphatic vessel
sections (pink) and tumor cells (brown) were detected by immunostaining with D2-40 and CDK2A/P16IN4Ka antibodies, respectively.
High magnification is shown in the insert. Lymphatic vessel sections (red) and tumor nodules (white) were automatically and
discriminatory segmented (bottom insert). (f) Binary image of lymphatic vessel sections and tumor nodules on the whole slide (g).
Intratumoral (i) and peritumoral regions (p) were manually discriminated (yellow dotted line). Peritumoral area was considered as the
area located within 2mm of depth from the tumor edges. White arrows represent the intra- and peritumoral areas that were analyzed.
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intra- and peritumoral lymphatic vessel density,
respectively. Also intra-observer variation exceeds
40% for both intra- and peritumoral lymphatic vessel
density. Using the computer-assisted technique, we
first determined that 93±3.5% of the lymphatic
vessels can be accurately detected on whole tissue
sections. Moreover, the quantification of intra- and
peritumoral lymphatic vessel density on five
successive slides reveals that the variability does
not exceed 5%.
Lymphatic Vessel Density
When analyzing the lymphatic vasculature of the
benign cervical stroma, we observe a prominent
lymphatic vessel density from the basal layer of the
epithelium to a depth of 2mm. Beyond this depth,
lymphatic vessels are sparsely distributed and show
a significant and acute drop in density (Po0.0001;
Figures 3a and b). Based on this observation, the
lymphatic vasculature has been characterized there-
after in the stromal layer located within 2mm of the
adjacent subepithelial basal membrane or the
nearest neoplastic invasive tumor edge. When
considering specifically the stroma of exocervical,
endocervical and transformation zone regions of the
normal cervix (Figures 3c–e), a high lymphatic
vessel density is detected under the transformation
zone. In the transformation zone and exocervix,
lymphatic vessels are distributed homogeneously
Figure 3 (a) Binary image of benign cervical tissue section. The green line represents the bottom limit of the stromal layer located within
2mm of depth from the epithelium basis. (b) Lymphatic vessel density measured within 2mm of depth in comparison with that detected
beyond this limit in benign cervical tissue. (c–e) Lymphatic vessel immunostaining (D2-40, pink) within the exocervix, the
transformation zone and the endocervix in benign cervical tissue. For the endocervix, pure glandular epithelium (left) and immature
squamous metaplastic zone (right) were presented. (f) Lymphatic vessel density measured under the three anatomical regions of the
benign uterine cervix (Endo, endocervix; Exo, exocervix; TZ, transformation zone). (g–i) Lymphatic vessel (D2-40, pink) and neoplastic
cells (p16INK4a, brown) immunostaining for (g) CIN3, (h) microinvasive and (i) 1B1 cervical neoplasia. (j) Lymphatic vessel density
measured within the perineoplastic area of CIN3, microinvasive (MI) and 1B1 cervical lesions in comparison with non-pathological
condition represented by the transformation zone of benign cervix (BC_TZ). Lymphatic vessel densities are expressed as the number of
lymphatic vessel sections/mm2. Scale bars represent 500mm. *Po0.05, ***Po0.001.
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while at the level of endocervix, they are hetero-
geneously distributed with low lymphatic vessel
density under pure glandular epithelium and high
lymphatic vessel density under immature squamous
metaplastic zones that may be regarded as a focal
transformation zone effect. The transformation zone-
associated lymphatic vessel density is higher than
lymphatic vessel density observed under the
exocervix (P¼ 0.0115) and not statistically different
from that measured under the endocervix
(P¼ 0.2475; Figure 3f).
Given the importance of the transformation zone
in cervical oncogenesis,26,27 we next compared
lymphatic vessel density under the transformation
zone of benign cervix, CIN3, microinvasive and
stage IB1 invasive neoplasia (Figures 3g–i). No
difference is seen between these different stages of
cancer progression (transformation zone/CIN3
Figure 3 (Continued).
Figure 4 (a) Double immunostaining of lymphatic endothelial cells (D2-40, pink) and proliferating cells (Ki67, brown). Magnification
represents a proliferating lymphatic vessel with Ki67-positive endothelial cell (arrow) next to a section with quiescent endothelial cell
(arrow head). Scale bar represents 500mm. (b) Proliferating lymphatic vessel density measured under the three anatomical regions of the
benign uterine cervix (Endo, endocervix; Exo, exocervix; TZ, transformation zone). (c) Proliferating lymphatic vessel density measured
within the perineoplastic area of CIN3, microinvasive (MI) and 1B1 cervical lesions in comparison with non-pathological condition
represented by the transformation zone of benign cervix (BC_TZ). Proliferating lymphatic vessel density is expressed as the number of
lymphatic vessel sections/mm2. *Po0.05, **P40.01, ***Po0.001.
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P¼ 0.0927, transformation zone/microinvasive
P¼ 0.5288, transformation zone/invasive 1B1 can-
cers P¼ 0.4349; Figure 3j). A further in depth
quantification shows that a higher lymphatic vessel
density is detected in the peritumoral area of IB1
cervical neoplasia compared with what was found
in the ‘deep tissue’ of benign cervical tissue, stroma
where lymphatic vessel density was initially low
(superior to 2mm from the adjacent epithelium;
Supplementary Figure S1).
In order to specifically investigate the lymphan-
giogenic activity, proliferating lymphatic vessels
were detected by double immunostaining using
anti-D2/40 and anti-Ki67 antibodies (Figure 4a).
The stromal density of proliferating lymphatic
vessels is again higher under the transformation
zone than under the exocervix (P¼ 0.0114;
Figure 4b). Transformation zone-associated prolifer-
ating lymphatic vessel density appears similar in
benign cervix, CIN3 (P¼ 0.6189) and microinvasive
lesions (P¼ 0.0889; Figure 4c). Proliferating lym-
phatic vessel density appears reduced in stage IB1
cervical cancers compared with microinvasive
lesions (Po0.0001), CIN3 (P¼ 0.0081) and benign
cervix (P¼ 0.0032).
Lymphatic Vessel Distribution
To better characterize the lymphatic vascular net-
work, a global stromal analysis has been achieved by
determining the distribution of lymphatic vessels in
the region surrounding the epithelial layer in
normal, preinvasive and invasive conditions. This
generates vessel distribution curves allowing to
determine the precise depth at which maximal
vessel density is observed. In benign cervix, the
distribution curve confirms the close vicinity
between the lymphatic vessels and the epithelium
basal membrane, both under the transformation
zone and under the endocervix (Figure 5a). Indeed,
the lymphatic vessel number peaks at a distance of
0.30mm±0.12 of depth under transformation zone
and 0.31mm±0.23 under the endocervix, respec-
tively. Oppositely, under the exocervix, the maximal
vessel number is detected at 0.65mm±0.52 to the
epithelium, reaches a minimal value and remains
constant thereafter. Notably, under the neoplastic
epithelia, a shift of lymphatic vessel distribution
toward the tumor edges is detected (Figure 5b).
Indeed, the maximal lymphatic vessel density peaks
at a lower distance under neoplasia compared
with that found under the transformation zone of
benign cervix (CIN3¼ 0.13mm±0.07, microinva-
sion¼ 0.13mm±0.08 and IB1 cervical cancers¼
0.11mm±0.07 versus transformation zone of benign
Figure 5 (a) Lymphatic vessel distribution under the three
anatomical regions of the benign uterine cervix (Endo, endocer-
vix; Exo, exocervix; TZ, transformation zone). (b) Lymphatic
vessel distribution within the perineoplastic area of CIN3,
microinvasive (MI) and 1B1 cervical lesions in comparison with
non-pathological condition represented by the transformation
zone of benign cervix (BC_TZ). Curves were normalized taking
the maximum of the control curve at one.
Table 1 Association between intra- and peritumoral LVD and
clinicopathologic tumor feature (LVSI and lymph node status)
Intratumoral LVD Peritumoral LVD
Mean±s.d. P-value Mean±s.d. P-value
Nodal metastasis
Absent (n¼34) 8.57±7.47 0.7214 9.52±4.12 0.4455
Present (n¼12) 7.78±3.79 9.33±6.03
LVSI
Absent (n¼21) 7.10±7.80 0.0550 8.76±4.64 0.3777
Present (n¼25) 9.21±5.62 10.72±6.27
Abbreviations: LVD, lymphatic vessel density; LVSI, lymphovascular
space invasion.
Results are represented as mean value±s.d. The Mann–Whitney test
was performed for comparison.
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cervix¼ 0.30±0.12; Po0.05). Moreover, at this
depth, a significant increase of relative vessel
number (ranging from 60 to 89%) is observed under
the neoplastic lesions.
Association between Lymphatic Vessel Density and
Spatial Distribution with Lymph Node Status and
Lymphovascular Space Invasion in IB1 Cervical
Cancer
We next focused our investigation on early stage
cervical cancer patients (FIGO stage IB1) by explor-
ing intra- and peritumoral lymphatic vasculature.
Lymphatic vessel density and spatial lymphatic
distribution were tested for their ability to predict
lymphovascular space invasion and lymph node
status. Intra- and peritumoral global lymphatic
vessel density are neither associated with lymph
node status nor with lymphovascular space invasion
positivity (Table 1). Conversely, a smaller distance
between the entire peritumoral lymphatic vessels
and tumor edges is associated with those related
lymphatic dissemination parameters (positive lym-
phovascular space invasion¼ 0.483mm±0.2 versus
negative lymphovascular space invasion¼ 0.640±
0.21mm, P¼ 0.0162 and positive lymph node¼
0.388±0.19 versus negative lymph node¼ 0.66
mm±0.19, P¼ 0.0039; Figures 6a and b). In fact, a
detailed analysis of the lymphatic vessel spatial
distribution reveals that while the number of peri-
tumoral lymphatic vessels peaks at similar distance
of the tumor edges (positive lymphovascular space
invasion¼ 0.11mm±0.04 negative lymphovascular
space invasion¼ versus 0.13mm±0.05; P40.05 and
positive lymph node¼ 0.10±0.07 versus negative
lymph node¼ 0.013±0.04; P40.05), a higher num-
ber at this depth is correlated with lymphovascular
space invasion (Po0.05) and lymph node metastasis
(Po0.01; Figures 6c and d).
Discussion
In early cervical cancer, the tumor lymphatic
vasculature profile is thought to be useful to early
predict the risk of lymph node extension. However,
owing to several limitations associated to the
conventional hot spot technique, no consensus
currently exists. In the present work, a detailed
analysis of the global cervical lymphatic vasculature
has been performed using an original and reprodu-
cible quantitative computerized assisted method.
We describe for the first time a prominent
lymphatic vessel density under the transformation
zone of healthy cervical tissues, which has been
characterized 30 years ago as the anatomical region
where precancerous and cancerous lesions deve-
lop.26 Interestingly, no statistical difference between
the transformation zone and the endocervix is due to
the presence of immature metaplasia, zones that
may be regarded as having a focal transformation
Figure 6 (a, b) Mean vessel distance between peritumoral
lymphatic vessels and the tumor edges. (c, d) Lymphatic vessel
distribution analysis within the peritumoral area of 1B1 cervical
cancers. Comparisons were performed regarding the presence/
absence of lymphatic vascular space invasion (LVSI) and lymph
node status (Nþ /N ). Curves were normalized taking the
maximum of the control curve at one. *Po0.05, **Po0.01.
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zone effect in the endocervix. The transformation
zone is increasingly drawing the attention of
researchers. It results from a metaplastic conver-
sion of glandular epithelial cells into squamous
epithelium in response to a repetitive hormone
induce vaginal pH acidification and sexual inter-
course injury.33 This metaplastic process is often
associated with local deregulation of cytokine and
chemokine production as well as inflammatory
response. Herfs et al34 hypothesized that this could
lead to the establishment of an immunosuppressive
microenvironment and potentiate tumor cell
progression to the underlying stroma. Moreover, an
elegant study reported that only a discrete popu-
lation of cells at the squamocolumnar junction
would be the precursors for most HPV-associated
cervical carcinomas.27 In this context, the presence
of a lymphangiogenic niche under the transforma-
tion zone of healthy cervical tissues reported herein
suggests the existence of a specific microenviron-
ment that could contribute to cancer progression.
These data also argue that for using this region as a
control to which neoplastic lymphatic vasculature
has to be compared.
To date, an early lymphangiogenic switch during
uterine cervical neoplasia progression appears well
accepted in the literature. Schoppmann et al35 were
first to observe a marked lymphatic vessel density
under preinvasive lesions compared with normal
cervical tissue but this failed to reach statistical
significance. These results were then confirmed in
three other studies that found a significant increase
of lymphatic vessel density under CIN2/3 lesions or
carcinoma in situ.10,11,15 A further rise of lymphan-
giogenesis in cervical cancers is supported by
Longattho-Filho and Yang’s studies10,14 while con-
tradictory results were reported by Schoppmann
et al35 and Gombos et al.15 Recently, Cimpean et al12
showed an activation of the lymphangiogenic acti-
vity in preinvasive and microinvasive before
decreasing its intensity in early cervical cancers.
However, in most studies, stromal region of benign
cervical tissue that was considered as non-
pathological condition (exocervix, endocervix or
transformation zone) was either not mentioned10,35
or corresponded to the exocervix.12,15,36 Discre-
pancies between early increase of lymphatic vessel
densities and our results showing a similar lym-
phatic vessel density detected under the transforma-
tion zone of benign cervix and preinvasive lesions
are thought to be due to an inappropriate choice for
the stromal region of benign cervix considered as
control.
In our experience, during early steps of cancer
progression (CIN3, micro-invasion and FIGO 1B1
neoplasia), no increase of lymphatic vessel density
is found when compared with transformation zone
of benign cervix. Our further observations of
lymphatic vessel distribution indicate that, lympha-
tic vessel density maintains a stable level through
the different stages of the neoplastic process
secondary to lymphangiogenesis occurring in the
deep tissue surrounding tumor invasive front in the
stroma where lymphatic vessel density was initially
low (superior to 2mm from the adjacent epithe-
lium). Moreover, the presence of Ki67-positive
lymphatic vessels under any degrees of neoplasia
supports that an ongoing lymphangiogenesis occurs
during cancer progression. Interestingly, topogra-
phical modifications with a shift of lymphatic
vessels toward the neoplastic edges are detected.
Especially, despite similar lymphatic vessel density,
a significant increase of the relative vessel number
in the vicinity of neoplasia is found when compared
the transformation zone of benign cervix. In accor-
dance with the lymphangiogenic switch presented
above, recent data reported high expression of
VEGF-C and/or VEGF-D by neoplastic cells before
the invasive process.9,11 In addition, Issa et al37
demonstrated that VEGF-C can promote tumor cell
migration toward lymphatic vessels by increasing
their proteolytic activity and motility as well as
lymphatic secretion of the chemoattractive protein
CCL21. Therefore, this supports the concept that
lymphangiogenesis occurring during cancer progres-
sion is a continuum of the lymphangiogenic activity
already present under the transformation zone of the
benign cervix.
In patients with early cervical cancer, the lym-
phatic vessel density was proposed as a new
promising factor capable to predict lymph node
extension. Especially, most clinical studies showed
that peritumoral lymphatic vessel density is asso-
ciated with an aggressiveness behavior and ap-
peared as a strong predictive factor of lymph node
metastasis.14–21,36 However, contradictory results
were reported by three others groups.10,23,24 Inter-
estingly, a few years ago, Van der Auwera et al22
proposed that these discrepancies are caused by a
lack of reproducibility when lymphatic vessel
density is measured by the conventional optical
microscopy (hot spot technique). They highlighted
that reliable quantification technique needs to be
developed for lymphangiogenesis quantification in
human solid tumors. In the present work, we
confirm that lymphatic vessel density determina-
tion through the hot spot technique is subjected to
high intra- and inter-observer variability. On the
contrary, the proposed computerized method shows
high accuracy and reproducibility in lymphatic
vessel detection. When global analysis of tumor
lymphatic vasculature is performed, intra- and
peritumoral lymphatic vessel density do not
correlated neither to lymph node metastasis nor to
lymphovascular space invasion. Nevertheless, we
demonstrate that the distribution of the lymphatic
vasculature must be taken into consideration when
characterizing the lymphatic vessel density. Indeed,
in IB1 cervical cancer, while similar lymphatic
vessel density is found, an increase of the relative
vessel number in the vicinity of the tumor edges is
associated with lymphovascular space invasion and
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lymph node metastasis. This indicates that interac-
tions between tumor and lymphatic endothelial
cells leading to a modification of the spatial
distribution of the lymphatic network could
promote tumor cell dissemination. In this context,
we aim to draw fundamental scientist’s attention on
the interest of a better characterization of the tumor
and lymphatic endothelial cell interactions. A better
understanding of such mechanisms could help to
find new specific predictive maker of lymph node
dissemination.
In conclusion, thanks to a novel computer-
assisted technique, a detailed reproducible and
reliable quantification of the lymphatic vasculature
can be performed on any immunostained tissue.
This approach allows to overcome limitations
associated with the hot spot technique and opens
new perspectives in the field of pathology. Notably,
we demonstrate that the spatial lymphatic vessel
distribution has to be taken into account when the
risk of nodal extension is tested. For these reasons,
we argue that global analysis of the tumor vascu-
lature is preferable to the traditional focal hot spot
analysis. Moreover, such analysis highlights the
need to concentrate on a better understanding of
tumor cell and lymphatic vessel interactions that are
involved in topographical modifications of the
lymphatic vasculature during cancer progression.
Of great interest is our finding of a specific
lymphangiogenic niche under the transformation
zone where cell transformation occurs. Finally,
similarly to cervical cancer, prognostic value of the
tumor lymphatic vessel density has been studied in
other human solid tumors such as breast, colorectal,
prostate, non-small cell lung cancers and melanoma
and interestingly contradictory results were fre-
quently observed.38 Consequently, the technology
developed in this study could potentially be used to
better characterize the lymphatic vasculature and
the risk of nodal extension in the context of other
tumors.
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